| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.3 | 0.07 |